"Prediction of neoadjuvant therapy response to HER2-positive and ..."

Min Fu et al. (2026)

> Home

Details and statistics

DOI: 10.1016/J.CMPB.2025.109130

access: closed

type: Journal Article

metadata version: 2025-12-21

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cmpb/FuZPHLLHMMC26
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cmpb/FuZPHLLHMMC26
Min Fu, Haichen Zhao, Jing Pang, Hui Hua, Xin Lin, Jingjing Liu, Yinxin He, Xiaoni Ming, Xinran Meng, Jingjing Chen:
Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study. Comput. Methods Programs Biomed. 273: 109130 (2026)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.